PCM
APLT

Penserra Capital Management’s Applied Therapeutics APLT Stock Holding History

Penserra Capital Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-595
Closed -$9K – 1367
2021
Q3 		$9K Hold
595
– – ﹤0.01% 1366
2021
Q2 		$12K Buy
595
+15
+3% +$284 ﹤0.01% 1259
2021
Q1 		$10K Buy
580
+65
+13% +$1.4K ﹤0.01% 1034
2020
Q4 		$11K Buy
+515
New +$10.7K ﹤0.01% 911

Other funds holding APLT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Penserra Capital Management's APLT Position: Q4 2021 in Review

Penserra Capital Management sold out of Applied Therapeutics (APLT) in Q4 2021, closing a stake of 595 shares — an estimated $9K sold.

Penserra Capital Management first reported a position in APLT in Q4 2020 and held it in 4 quarters. The position peaked at $12K in Q2 2021. 69 funds tracked by Wall St. Rank hold APLT as of Q4 2021.

  • Penserra Capital Management reported no remaining Applied Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 595 Applied Therapeutics shares in Q4 2021, an estimated $9K.
  • Penserra Capital Management first reported a position in Applied Therapeutics in Q4 2020 and held it in 4 quarters.
  • Penserra Capital Management's Applied Therapeutics position peaked at $12K in Q2 2021.
  • 69 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.